iNCOVACC, the world’s first COVID-19 intranasal vaccine, will be launched on January 26. The intranasal coronavirus vaccine has been developed by India’s Bharat Biotech. Speaking at an event at the Maulana Azad National Institute of Technology (MANIT), Krishna Ella, the company’s chairman and managing director, said, “Our nasal vaccine will be officially launched on January 26, on Republic Day.”
The company, in December 2022, got the approval for the primary 2-dose schedule, and as a heterologous booster dose. Before that, the Central Drugs Standard Control Organisation (CDSCO) had approved the restricted use of the intranasal vaccine in emergency situations in the age group of 18 and above.